Tracking markers for neurodegenerative diseases
Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Hormones & metabolism, Mental health clinical trials.
This study tracks changes in people with Parkinson's disease, other movement disorders, or cognitive decline to find better ways to measure disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Parkinson's disease, another movement disorder (like multiple system atrophy, progressive supranuclear palsy, or essential tremor), or a cognitive issue (like dementia or memory problems).
- You are willing to participate and understand the study procedures.
- You can complete the research assessments.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking for proteins in blood and other body fluids that could help detect brain diseases like Parkinson's, Alzheimer's, and ALS early. It aims to improve diagnosis and future treatments.
This study is looking for people with neurodegenerative diseases (like Alzheimer's, Parkinson's, ALS) to help researchers find new markers in the body that could help understand these conditions better and possibly lead to better treatments.
This study looks for “biomarkers” (measurable signs in blood or other samples) in people with motor neuron disease and frontotemporal dementia spectrum conditions. It also compares those findings with matched caregivers, to understand what might be happening in these diseases.
This study looks at how your symptoms, brain imaging (MRI), and genetic factors relate to neurodegenerative conditions. It may help researchers better understand what causes these illnesses and how to classify them.
This study looks for early signs of brain diseases like Alzheimer's or Parkinson's before symptoms start. Participants will have MRIs and blood tests to find markers that could predict future disease.
This study helps people understand a protein called alpha-synuclein that may be related to memory problems and movement disorders. Researchers will either test your spinal fluid or skin to look for this protein, then discuss the results with you and measure how you're doing over time.
Hear when a new Neurodegenerative Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.